Cite
MLA Citation
Nada Albarakati et al.. “Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy.” Molecular oncology, vol. 9, no. 1, n.d., pp. 204–217. http://access.bl.uk/ark:/81055/vdc_100045418883.0x000062